How are one class of diabetes drugs related to cancer risk? Elizabeth Tracey reports

from Health Newsfeed – Johns Hopkins Medicine Podcasts · host Elizabeth Tracey

GLP-1 agonists are a class of drugs originally developed to treat diabetes but have been shown to be helpful for weight loss. Now a new study looks at whether their use reduces the risk of obesity related cancers. William Nelson, … How are one class of diabetes drugs related to cancer risk? Elizabeth Tracey reports Read more →

Episode metadata supplied by the publisher feed · Published Jul 3, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

How are one class of diabetes drugs related to cancer risk? Elizabeth Tracey reports

0:00 1:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Health Newsfeed – Johns Hopkins Medicine Podcasts?

This episode is 1 minute long.

When was this Health Newsfeed – Johns Hopkins Medicine Podcasts episode published?

This episode was published on July 3, 2026.

Can I download this Health Newsfeed – Johns Hopkins Medicine Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!